Meeting
2013 Breast Cancer Symposium
Recurrence score across the age spectrum: Is there an age discrimination?
Authors
Franz Omar Smith
H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Franz Omar Smith , Marie Catherine Lee , Geza Acs , William J. Fulp , Ji-Hyun Lee , Naznin Khakpour , John Kiluk , Christine Laronga
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A
Track
Local/Regional Therapy,Risk Assessment, Prevention, Detection, and Screening
Sub Track
Genomics
Citation
J Clin Oncol 31, 2013 (suppl 26; abstr 27)
DOI
10.1200/jco.2013.31.26_suppl.27
Abstract #
27
Poster Bd #
C9
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Selection for Oncotype Dx testing among young women with early-stage ER+/HER2- breast cancer.
First Author: Philip Daniel Poorvu
Poster
2014 ASCO Annual Meeting
Association between androgen receptor (AR) expression, Ki-67, and the 21-gene recurrence score in early breast cancer.
First Author: Francisco Emilio Vera-Badillo
Poster
2013 ASCO Annual Meeting
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence.
First Author: Maria Vittoria Dieci
Poster
2012 Breast Cancer Symposium
Age, hormone receptor status, ethnicity, and adjuvant radiation therapy as predictive factors for cancer-related death in patients age 70 and older with early-stage pT1a,b N0 breast cancer: An NCI-SEER database analysis.
First Author: Akkamma Ravi